Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs MyFastRx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and MyFastRx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 58 · Grade C

MyFastRx

Visit MyFastRx Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 79 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make MyFastRx a bad call — it's best for cash-pay patients comparing a short initial purchase with a longer prepaid commitment. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
78
Supply Reliability
95
73
Transparency
90
88
Access Breadth
93
90
Clinical Oversight
92
74
Track Record
88
68
CoreAge RxBrief Score 94 · 79MyFastRx

Price, coverage & the tracker

CoreAge RxMyFastRx
Brief Score94/100 (A)79/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$139/mo ongoing

New customers: $69 first month with MY70; annual option $948 upfront.

Full price details

$139/mo ongoing; $69 first month for new customers with MY70; $948 prepaid for 12 months ($79/mo equivalent)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$199/mo ongoing

New customers: $129 first month with MY70; annual option $1,488 upfront.

Full price details

$199/mo ongoing; $129 first month for new customers with MY70; $1,488 prepaid for 12 months ($124/mo equivalent)

CoverageUS only; restrictions by state, confirmed at intakeAvailability depends on state, treatment and clinical eligibility
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

MyFastRx: Standard ongoing prices are $139/month for semaglutide and $199/month for tirzepatide. Introductory discounts and annual prepaid equivalents are separate offers.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.